Elevance continues to expect its Medicare Advantage program to hit 2.2 million to 2.25 million members in 2025, and for adjusted earnings to be $34.15 to $34.85 a share.

Elevance Health (ELV) stock slips amid pressure from UnitedHealth's (UNH) Q1 results, even as its own early Q1 2025 results ...

Elevance Health said on Thursday it expects first-quarter profit above estimates, helped by medical cost trends that were in line with its expectations.

CVS, Humana and Elevance shares are moving lower on Thursday after UnitedHealth reported earnings prior to the market opening.

Elevance (ELV) stock thrives with fee-based plans, preventive care, and disciplined capital management, ensuring growth and strong investor returns. See more.

Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to ...

(Reuters) -Elevance Health on Thursday forecast a first-quarter profit above estimates and maintained its annual profit view, hours after industry bellwether UnitedHealth cut its outlook and sparked a ...

In a report released today, Ryan Langston from TD Cowen maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target ...

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against other best medical stocks to buy according to billionaires. Some experts view medical ...

Truist raised the firm’s price target on Elevance Health (ELV) to $510 from $480 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results in Healthcare ...